[Cardiovascular treatment in chronic kidney disease]

Area of Science:

• Cardiorenal medicine
• Clinical practice guidelines
• Pharmacotherapy

Background:

• Combined cardiac and renal diseases present significant clinical challenges with high morbidity and mortality risks.
• Cardiorenal patients are often underrepresented in clinical trials, leading to weaker treatment guidelines.
• Kidney function impacts medication approval and choice, complicating treatment strategies.

Approach:

• This review synthesizes current knowledge on managing cardiorenal conditions.
• It focuses on critical treatment areas influenced by coexisting chronic kidney disease.
• The review highlights challenges in evidence-based recommendations for this patient population.

Key Points:

• Treatment decisions for cardiorenal patients require careful consideration of kidney function.
• Guideline recommendations may be less robust for cardiorenal patients compared to those with isolated cardiac disease.
• Medication choices are often restricted or require dose adjustments based on renal impairment.

Conclusions:

• Effective management of cardiorenal disease necessitates a multidisciplinary approach.
• Further research is needed to strengthen evidence-based guidelines for cardiorenal patients.
• Optimizing treatment requires a nuanced understanding of drug interactions and renal function.